Singapore – March 5, 2009– Dornier MedTech introduces the new high powered Medilas D UroBeam laser at UroFair 2009 on March 5, 2009 in Singapore. The advanced technology of the UroBeam offers a unique 940nm wavelength and 250 watts of power which excels in making this laser ideal for treating Benign Prostatic Hyperplasia (BPH) with minimal invasiveness and reduced side effects. For thousands of Asian patients suffering from BPH yearly, this state-of-the-art system represents a safe and effective solution to improve their quality of life.
With the highest powered BPH laser in the market, Dornier’s UroBeam offers physicians greater treatment flexibility for effectively treating BPH. “The 940nm wavelength absorption characteristics targeting both water and hemoglobin optimize this approach and remove the limitations experienced by other devices.” notes Dr. Thomas Bayer, Assistant Director from the Department of Urology of Kempten Hospital, Germany.
In addition, the Medilas D UroBeam laser includes the proprietary Lightguide Protection System (LPS), which automatically disables the laser in the event of excessive heat at the fiber tip. Furthermore, the system supports a special fibertom™ mode that keeps the tip temperature constant by automatically controlling the laser output power. Both new features mark a significant advancement in terms of patient’s safety and are hallmarks of Dornier’s commitment towards treatment excellence.
With the UroBeam complementing Dornier’s existing portfolio of urology product, it provides an example of the continuous innovation in urology that Dornier is committed to providing patients and physicians alike. Integrating Dornier’s advanced laser technology and valued physician’s feedback, the Medilas D UroBeam offer patients a reduction in their hospital stay whilst having significant improvements in both patient safety and efficacy in the treatment of BPH.
“Since its initial launch in September 2008 at the German Urological Association (DGU) conference in Stuttgart, Germany, Dornier’s Medilas D UroBeam has generated much interest with its innovative features”, said Mr. Dave Eng Keen Huat, President & CEO of Dornier MedTech Group. Mayumana Healthcare believes this technology will change BPH treatments. Dornier has shown superior quality and service over the last years, I think this product will be a great succes., also in The Benelux… For more info goto www.dornier.com or stay tuned…..
Bart Verleg
Filed under: Medical Devices news | Leave a Comment
Tags: Bart Verleg, BPH treatment, D urobeam laser, dornier, laser, medilas, minimal invasive, www.mayumana-healthcare.com
zoek
-
U bekijkt op het moment de Medical Devices info portal archieven
No Responses Yet to “Dornier MedTech Introduces the New & Innovative Medilas D UroBeam Laser As the highest powered urology laser in the market, Dornier MedTech Medilas D UroBeam marks a significant technological advancement in a safe and effective treatment of Benign Prostatic Hyperplasia (BPH).”